Ravindra Kumar, VP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 1,500 shares at $40.09 ($61K) on 2015-01-12, disclosed to the SEC on 2015-01-13.
Scheduled sale ($61k) by VP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.09 | 400 | $16K | 26.2% |
| 2 | $41.06 | 1,100 | $45K | 73.8% |
| Total | $40.80 avg | 1,500 | $61K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |